GlassScriptPhysician profile
Frank E Okosun
NPI 1093027807
$4,430.57
in general payments reported to CMS, 2019-2025
46 companies · $847 in 2025
The $847 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $106 · 2021: $797 · 2022: $438 · 2023: $1,020 · 2024: $757 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,624.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,108.84 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $437.03 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $293.73 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $289.93 | 2019-2024 | Trintellix |
| Amarin Pharma, INC. | $215.33 | 2019-2021 | |
| Medtronic, INC. | $200.72 | 2023-2024 | Interstim |
| Abbvie INC. | $167.50 | 2021-2024 | |
| Glaxosmithkline, LLC. | $144.33 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $135.50 | 2022-2025 | Otezla, Repatha, Otezla |
| Exact Sciences Corporation | $117.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Scilex Pharmaceuticals INC. | $106.04 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.15 | 2022-2024 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.12 | 2020-2021 | |
| Astellas Pharma US INC | $61.60 | 2019-2023 | Veozah |
| Teva Pharmaceuticals USA, INC. | $60.68 | 2022-2023 | Austedo Xr |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Okosun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.